Abstract
A study of buprenorphine prescribing for opioid use disorder (OUD) from 2015 to 2019 has found that misuse of the drug decreased during that time period. The study, by researchers from the National Institute on Drug Abuse (NIDA), which funded the development of buprenorphine for OUD, was published last week in JAMA Network Open.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
